UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Discovery of a Novel, Potent Spirocyclic Series of γ‑Secretase Inhibitors

Journal of medicinal chemistry, 2015-11, Vol.58 (22), p.8806-8817

2015

Volltextzugriff (PDF)

Structural Basis for Potency and Promiscuity in Poly(ADP-ribose) Polymerase (PARP) and Tankyrase Inhibitors

Journal of medicinal chemistry, 2017-02, Vol.60 (4), p.1262-1271

2017

Volltextzugriff (PDF)

Discovery of SHP2-D26 as a First, Potent, and Effective PROTAC Degrader of SHP2 Protein

Journal of medicinal chemistry, 2020-07, Vol.63 (14), p.7510-7528

2020

Volltextzugriff (PDF)

Identification of TNO155, an Allosteric SHP2 Inhibitor for the Treatment of Cancer

Journal of medicinal chemistry, 2020-11, Vol.63 (22), p.13578-13594

2020

Volltextzugriff (PDF)

Tranylcypromine Based Lysine-Specific Demethylase 1 Inhibitor: Summary and Perspective

Journal of medicinal chemistry, 2020-12, Vol.63 (23), p.14197-14215

2020

Volltextzugriff (PDF)

Small-molecule inhibitors of the MDM2-p53 protein-protein interaction (MDM2 Inhibitors) in clinical trials for cancer treatment

Journal of medicinal chemistry, 2015-02, Vol.58 (3), p.1038-1052

2015

Volltextzugriff (PDF)

Discovery of CC-90011: A Potent and Selective Reversible Inhibitor of Lysine Specific Demethylase 1 (LSD1)

Journal of medicinal chemistry, 2020-12, Vol.63 (23), p.14522-14529

2020

Volltextzugriff (PDF)

Recent Advances of SHP2 Inhibitors in Cancer Therapy: Current Development and Clinical Application

Journal of medicinal chemistry, 2020-10, Vol.63 (20), p.11368-11396

2020

Volltextzugriff (PDF)

Discovery and Optimization of Potent, Cell-Active Pyrazole-Based Inhibitors of Lactate Dehydrogenase (LDH)

Journal of medicinal chemistry, 2017-11, Vol.60 (22), p.9184-9204

2017

Volltextzugriff (PDF)

Overview of the Development of Glutaminase Inhibitors: Achievements and Future Directions

Journal of medicinal chemistry, 2019-02, Vol.62 (3), p.1096-1115

2019

Volltextzugriff (PDF)

Discovery of Orally Bioavailable, Quinoline-Based Aldehyde Dehydrogenase 1A1 (ALDH1A1) Inhibitors with Potent Cellular Activity

Journal of medicinal chemistry, 2018-06, Vol.61 (11), p.4883-4903

2018

Volltextzugriff (PDF)

Identification of (R)‑N‑((4-Methoxy-6-methyl-2-oxo-1,2-dihydropyridin-3-yl)methyl)-2-methyl-1-(1-(1-(2,2,2-trifluoroethyl)piperidin-4-yl)ethyl)‑1H‑indole-3-carboxamide (CPI-1205), a Potent and Selective Inhibitor of Histone Methyltransferase EZH2, Suitable for Phase I Clinical Trials for B‑Cell Lymphomas

Journal of medicinal chemistry, 2016-11, Vol.59 (21), p.9928-9941

2016

Volltextzugriff (PDF)

Challenges in the Discovery of Indoleamine 2,3-Dioxygenase 1 (IDO1) Inhibitors

Journal of medicinal chemistry, 2015-12, Vol.58 (24), p.9421-9437

2015

Volltextzugriff (PDF)

Discovery of a Potent and Specific M. tuberculosis Leucyl-tRNA Synthetase Inhibitor: (S)‑3-(Aminomethyl)-4-chloro-7-(2-hydroxyethoxy)benzo[c][1,2]oxaborol-1(3H)‑ol (GSK656)

Journal of medicinal chemistry, 2017-10, Vol.60 (19), p.8011-8026

2017

Volltextzugriff (PDF)

Design and Synthesis of Potent and Multifunctional Aldose Reductase Inhibitors Based on Quinoxalinones

Journal of medicinal chemistry, 2015-02, Vol.58 (3), p.1254-1267

2015

Volltextzugriff (PDF)

Group-Based Optimization of Potent and Cell-Active Inhibitors of the von Hippel–Lindau (VHL) E3 Ubiquitin Ligase: Structure–Activity Relationships Leading to the Chemical Probe (2S,4R)‑1-((S)‑2-(1-Cyanocyclopropanecarboxamido)-3,3-dimethylbutanoyl)-4-hydroxy‑N‑(4-(4-methylthiazol-5-yl)benzyl)pyrrolidine-2-carboxamide (VH298)

Journal of medicinal chemistry, 2018-01, Vol.61 (2), p.599-618

2018

Volltextzugriff (PDF)

Discovery of First-in-Class Protein Arginine Methyltransferase 5 (PRMT5) Degraders

Journal of medicinal chemistry, 2020-09, Vol.63 (17), p.9977-9989

2020

Volltextzugriff (PDF)

Discovery of Soluble Epoxide Hydrolase Inhibitors from Chemical Synthesis and Natural Products

Journal of medicinal chemistry, 2021-01, Vol.64 (1), p.184-215

2021

Volltextzugriff (PDF)

Macrocycles Are Great Cycles: Applications, Opportunities, and Challenges of Synthetic Macrocycles in Drug Discovery

Journal of medicinal chemistry, 2011-04, Vol.54 (7), p.1961-2004

2011

Volltextzugriff (PDF)

Discovery of a 3‑(4-Pyrimidinyl) Indazole (MLi-2), an Orally Available and Selective Leucine-Rich Repeat Kinase 2 (LRRK2) Inhibitor that Reduces Brain Kinase Activity

Journal of medicinal chemistry, 2017-04, Vol.60 (7), p.2983-2992

2017

Volltextzugriff (PDF)

PAINS in the Assay: Chemical Mechanisms of Assay Interference and Promiscuous Enzymatic Inhibition Observed during a Sulfhydryl-Scavenging HTS

Journal of medicinal chemistry, 2015-03, Vol.58 (5), p.2091-2113

2015

Volltextzugriff (PDF)

High-Throughput Screening for the Discovery of Enzyme Inhibitors

Journal of medicinal chemistry, 2020-10, Vol.63 (19), p.10742-10772

Lloyd, Matthew D

2020

Volltextzugriff (PDF)

Pyrazole-Based Lactate Dehydrogenase Inhibitors with Optimized Cell Activity and Pharmacokinetic Properties

Journal of medicinal chemistry, 2020-10, Vol.63 (19), p.10984-11011

2020

Volltextzugriff (PDF)

Unexpected Noncovalent Off-Target Activity of Clinical BTK Inhibitors Leads to Discovery of a Dual NUDT5/14 Antagonist

Journal of medicinal chemistry, 2024-05, Vol.67 (9), p.7245-7259

2024

Volltextzugriff (PDF)

1 – 25 von 2.672

Suche als RSS-Feed

Aktive Filter

KollektionSpringer Nature - Complete Springer Journals

Zeitschrift / SerieJournal Of Medicinal Chemistry

Nur zeigenGeprüft (Peer-Review)

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Mit Volltextzugriff
(2.672)

Publikationsform

Artikel
(2.672)

Sprache

Englisch
(2.672)

Erscheinungsjahr

n.n

Thema

Chemistry, Medicinal
(2.443)
Life Sciences & Biomedicine
(2.443)
Pharmacology & Pharmacy
(2.443)
Science & Technology
(2.443)
Enzyme Inhibitors - Pharmacology
(1.693)
Humans
(1.636)
Structure-Activity Relationship
(1.628)
Enzyme Inhibitors - Chemistry
(1.484)
Animals
(1.347)
Biological And Medical Sciences
(1.330)
Medical Sciences
(1.215)
Enzyme Inhibitors - Chemical Synthesis
(1.200)
Pharmacology. Drug Treatments
(1.199)
Models, Molecular
(933)
Rats
(574)
Molecular Structure
(571)
Mice
(556)
Drug Design
(501)
Crystallography, X-Ray
(462)
Antineoplastic Agents
(358)

15 weitere anzeigen...

Weniger anzeigen...

Kollektion

MEDLINE
(2.659)
Elsevier Journal Backfiles on ScienceDirect (DFG Nationallizenzen)
(1)
JSTOR
(1)
EZB Electronic Journals Library
(1)
Ingenta
(1)
Elsevier ScienceDirect Journals Complete
(1)
Publisher or Other Site
(1)
SpringerLink E-Journals
(0)

3 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

J. Med. Chem
(13)
J. Med. Chem.;
(6)
Geochimica Et Cosmochimica Acta
(1)
Inform
(1)
J Med Chem
(1)
J.Med.Chem.49:839,2006
(1)
J.Mol.Chem.44:1530,2001
(1)
Proceedings Of The National Academy Of Sciences - Pnas
(1)

3 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Discovery of a Novel, Potent Spirocyclic Series of γ‑Secretase Inhibitors

Structural Basis for Potency and Promiscuity in Poly(ADP-ribose) Polymerase (PARP) and Tankyrase Inhibitors

Discovery of SHP2-D26 as a First, Potent, and Effective PROTAC Degrader of SHP2 Protein

Identification of TNO155, an Allosteric SHP2 Inhibitor for the Treatment of Cancer

Tranylcypromine Based Lysine-Specific Demethylase 1 Inhibitor: Summary and Perspective

Small-molecule inhibitors of the MDM2-p53 protein-protein interaction (MDM2 Inhibitors) in clinical trials for cancer treatment

Discovery of CC-90011: A Potent and Selective Reversible Inhibitor of Lysine Specific Demethylase 1 (LSD1)

Recent Advances of SHP2 Inhibitors in Cancer Therapy: Current Development and Clinical Application

Discovery and Optimization of Potent, Cell-Active Pyrazole-Based Inhibitors of Lactate Dehydrogenase (LDH)

Overview of the Development of Glutaminase Inhibitors: Achievements and Future Directions

Discovery of Orally Bioavailable, Quinoline-Based Aldehyde Dehydrogenase 1A1 (ALDH1A1) Inhibitors with Potent Cellular Activity

Discovery of a Novel and Selective Indoleamine 2,3-Dioxygenase (IDO-1) Inhibitor 3‑(5-Fluoro‑1H‑indol-3-yl)pyrrolidine-2,5-dione (EOS200271/PF-06840003) and Its Characterization as a Potential Clinical Candidate

Challenges in the Discovery of Indoleamine 2,3-Dioxygenase 1 (IDO1) Inhibitors

Discovery of a Potent and Specific M. tuberculosis Leucyl-tRNA Synthetase Inhibitor: (S)‑3-(Aminomethyl)-4-chloro-7-(2-hydroxyethoxy)benzo[c][1,2]oxaborol-1(3H)‑ol (GSK656)

Design and Synthesis of Potent and Multifunctional Aldose Reductase Inhibitors Based on Quinoxalinones

Discovery of First-in-Class Protein Arginine Methyltransferase 5 (PRMT5) Degraders

Discovery of Soluble Epoxide Hydrolase Inhibitors from Chemical Synthesis and Natural Products

Macrocycles Are Great Cycles: Applications, Opportunities, and Challenges of Synthetic Macrocycles in Drug Discovery

Discovery of a 3‑(4-Pyrimidinyl) Indazole (MLi-2), an Orally Available and Selective Leucine-Rich Repeat Kinase 2 (LRRK2) Inhibitor that Reduces Brain Kinase Activity

PAINS in the Assay: Chemical Mechanisms of Assay Interference and Promiscuous Enzymatic Inhibition Observed during a Sulfhydryl-Scavenging HTS

High-Throughput Screening for the Discovery of Enzyme Inhibitors

Pyrazole-Based Lactate Dehydrogenase Inhibitors with Optimized Cell Activity and Pharmacokinetic Properties

Unexpected Noncovalent Off-Target Activity of Clinical BTK Inhibitors Leads to Discovery of a Dual NUDT5/14 Antagonist

Aktive Filter

Suchergebnisse filtern